Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 0.39%, near the low end of its 5-year range (0.00%–0.74%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 0.04%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.04%
DEBT TO ASSETS RATIO AVG 3Y
0.26%
DEBT TO ASSETS RATIO AVG 5Y
0.39%
DEBT TO ASSETS RATIO AVG 10Y
0.59%
DEBT TO ASSETS RATIO AVG 15Y
4.27%
DEBT TO ASSETS RATIO AVG 20Y
5.42%
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 597 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Lisata Therapeutics, Inc.
Market Cap
$11.38M
Debt to Assets Ratio
0.00%
TTM Avg
0.04%
3Y Avg
0.26%
5Y Avg
0.39%
Market Cap
$11.50M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.50M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.17M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.75M
Debt to Assets Ratio
0.69%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.87M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.75M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lisata Therapeutics, Inc. (LSTA) | $11.38M | 0.00% | 0.04% | 0.26% | 0.39% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.50M | 0.01% | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.50M | 0.00% | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.17M | 0.01% | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.09M | 0.31% | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $11.75M | 0.69% | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.01M | 0.02% | N/A | N/A | N/A |
| Lantern Pharma Inc. (LTRN)vs › | $11.87M | 0.00% | N/A | N/A | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.75M | 0.06% | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.67M | 0.00% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
3.69
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.19% |
| 2025-03-31 | 0.32% |
| 2024-12-31 | 0.39% |
| 2024-09-30 | 0.47% |
| 2024-06-30 | 0.41% |
| 2024-03-31 | 0.36% |
| 2023-12-31 | 0.31% |
| 2023-09-30 | 0.28% |
| 2023-06-30 | 0.61% |
| 2023-03-31 | 0.63% |
| 2022-12-31 | 0.66% |
| 2022-09-30 | 0.70% |
| 2022-06-30 | 0.65% |
| 2022-03-31 | 0.68% |
| 2021-12-31 | 0.74% |
| 2021-09-30 | 0.34% |
| 2021-06-30 | 0.41% |
| 2021-03-31 | 0.47% |
| 2020-12-31 | 1.73% |
| 2020-09-30 | 1.69% |
| 2020-06-30 | 2.12% |
| 2020-03-31 | 1.53% |
| 2019-12-31 | 3.60% |
| 2019-09-30 | 1.16% |
| 2019-06-30 | 1.05% |
| 2019-03-31 | 0.96% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.04% |
| 2018-03-31 | 0.16% |
| 2017-12-31 | 0.25% |
| 2017-09-30 | 0.53% |
| 2017-06-30 | 1.46% |
| 2017-03-31 | 12.62% |
| 2016-12-31 | 13.10% |
| 2016-09-30 | 11.56% |
| 2016-06-30 | 17.61% |
| 2016-03-31 | 16.56% |
| 2015-12-31 | 29.33% |
| 2015-09-30 | 14.06% |
| 2015-06-30 | 13.32% |
| 2015-03-31 | 14.08% |
| 2014-12-31 | 13.18% |
| 2014-09-30 | 12.91% |
| 2014-06-30 | 3.70% |
| 2014-03-31 | 5.66% |
| 2013-12-31 | 4.62% |
| 2013-09-30 | 6.99% |
| 2013-06-30 | 7.17% |
| 2013-03-31 | 7.39% |
| 2012-12-31 | 7.01% |
| 2012-09-30 | 2.85% |
| 2012-06-30 | 2.72% |
| 2012-03-31 | 11.77% |
| 2011-12-31 | 10.21% |
| 2011-09-30 | 9.07% |
| 2011-06-30 | 13.22% |
| 2011-03-31 | 10.96% |
| 2010-12-31 | 8.81% |
| 2010-09-30 | 12.50% |
| 2010-06-30 | 15.15% |
| 2010-03-31 | 18.24% |
| 2009-12-31 | 11.31% |
| 2009-09-30 | 1.71% |
| 2009-06-30 | 0.33% |
| 2009-03-31 | 68.22% |
| 2008-12-31 | 0.81% |
| 2008-09-30 | 1.39% |
| 2008-06-30 | 3.62% |
| 2008-03-31 | 4.55% |
| 2007-12-31 | 1.82% |
| 2007-09-30 | 2.72% |
| 2007-06-30 | 20.08% |
| 2007-03-31 | 14.17% |
| 2006-12-31 | 23.99% |
| 2006-09-30 | 13.95% |
| 2006-06-30 | 53.15% |
| 2006-03-31 | 108.30% |
| 2005-12-31 | 54.41% |
| 2005-09-30 | 1017.27% |
| 2005-06-30 | 1130.98% |
| 2005-03-31 | 826.68% |
| 2004-12-31 | 572.30% |
| 2004-09-30 | 126.97% |
| 2004-06-30 | 762.38% |
| 2004-03-31 | 441.12% |
| 2003-12-31 | 131.39% |
| 2003-09-30 | 93.17% |
| 2003-06-30 | 28.71% |
| 2003-03-31 | 18.00% |
| 2002-12-31 | 13.28% |
| 2002-09-30 | 10.87% |
